Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H1DV
|
||||
Former ID |
DNC007988
|
||||
Drug Name |
N-phenyl-5,6-dip-tolylpyrazine-2-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528851] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H21N3O
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)C2=NC=C(N=C2C3=CC=C(C=C3)C)C(=O)NC4=CC=CC<br />=C4
|
||||
InChI |
1S/C25H21N3O/c1-17-8-12-19(13-9-17)23-24(20-14-10-18(2)11-15-20)28-22(16-26-23)25(29)27-21-6-4-3-5-7-21/h3-16H,1-2H3,(H,27,29)
|
||||
InChIKey |
AKCXCZPEESTMSV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [528851] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.